36.000
+0,00%
2026-10-14
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.2% | +7.8% | 3 / 3 | +17.6% | +0.70 pp | -0.41 pp | +15.8% | 0.22 | 7.33 | 462 | +17,6% | 34,1 | +11,4% | 7.33 | 9.79 | −25,1% |
| Pts | 0 | 0 | 12 | 8 | 8 | 4 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 36.000 (close price on 2026-10-14)EPS (TTM): 4.911
Financial charts
1.Revenue & growth
VND bn462Q2/26
1.Revenue & growth
VND bn462Q2/26
2.Profit & growth
VND bn34,1Q2/26
3.Profit mix (Penman)
VND bn158Q2/26
4.Margins & cost structure
%19.5%Q2/26
5.Returns & cash cycle
% · days19.8%Q2/26
6.Earnings quality & cash
VND bn221Q2/26
7.Asset structure
VND bn1.337Q2/26
8.Funding & debt health
VND bn · times1.337Q2/26
9.Revenue backlog
VND bn0,12Q2/26
10.Valuation
times · %7,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.264Q2/26
Adjusted EPS growth, latest quarter
11.4%
Average adjusted EPS growth, 3 quarters
8.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26